BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33090393)

  • 1. LncRNA MEG3 inhibits the growth, invasion and migration of Wilms' tumor via Wnt/β-catenin pathway.
    Teng GY; Wang YJ; Geng M; Jiang ZP
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9899-9907. PubMed ID: 33090393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway.
    Zhu KR; Sun QF; Zhang YQ
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5691-5698. PubMed ID: 31298321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.
    Yao FZ; He R; Jiang YC; Hou Y; Qian D
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9889-9898. PubMed ID: 33090392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TCF3 in Wilms' tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis
    Zhou N; Yan B; Ma J; Jiang H; Li L; Tang H; Ji F; Yao Z
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
    Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MEG3 promotes proliferation and differentiation of osteoblasts through Wnt/β-catenin signaling pathway.
    Li XG; Liu SC; Qiao XF; Kong Y; Liu JG; Peng XM; Wang YX; Abdulkarim Mohammed Al-Mohana RA
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4521-4529. PubMed ID: 31210279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
    Xiao X; Li L; Cui JC; Wang Y
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA ENST00000434223 inhibits the progression of renal cancer through Wnt/hygro-catenin signaling pathway.
    Luo NQ; Ma DR; Yang XC; Liu Y; Zhou P; Guo LJ; Huang XD
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6868-6877. PubMed ID: 31486486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of LncRNA HOTAIR on the proliferation, apoptosis and drug resistance of Wilms tumor cells through Wnt/β-catenin signaling pathway].
    Yang LL; Cao GH; Liu YJ; Liu CH
    Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):769-774. PubMed ID: 34289571
    [No Abstract]   [Full Text] [Related]  

  • 10. LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway.
    Li P; Gao Y; Li J; Zhou Y; Yuan J; Guan H; Yao P
    J Cell Biochem; 2018 Sep; 119(9):7498-7505. PubMed ID: 29781534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing long non-coding RNA MEG3 accelerates tibia fraction healing by regulating the Wnt/β-catenin signalling pathway.
    Liu YB; Lin LP; Zou R; Zhao QH; Lin FQ
    J Cell Mol Med; 2019 Jun; 23(6):3855-3866. PubMed ID: 30955246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of lncRNA MEG8 Represses the Viability, Migration, and Invasion of Wilms' Tumor Cells through Mediating miR-23a-3p/CRK Axis.
    Shen J; Shu Q
    Urol Int; 2022; 106(10):1075-1087. PubMed ID: 34518485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA GNAS-AS1 promotes cell migration and invasion via regulating Wnt/β-catenin pathway in nasopharyngeal carcinoma.
    Wang XQ; Xu H; Wang CH; Xie H
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3077-3084. PubMed ID: 32271425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of miR-190b promoted growth, invasion, migration and inhibited apoptosis of Wilms' tumor cells by repressing the PTEN expression.
    An NN; Shawn J; Peng JP; Wu MD; Huang LG
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):961-969. PubMed ID: 29509256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway.
    Liu XB; Han C; Sun CZ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):110-117. PubMed ID: 29364477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
    Li JL; Luo P
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
    Gao Y; Lu X
    Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing long non-coding RNA SNHG6 restrains proliferation, migration and invasion of Wilms' tumour cell lines by regulating miR-15a.
    Su L; Wu A; Zhang W; Kong X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2670-2677. PubMed ID: 31257923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.